Valiant Health helps industry, policymakers, payers, HTA bodies, innovation ecosystems, hospitals, and clinicians understand which healthcare AI technologies are credible, assessable, adoptable, and reimbursable.

Valiant was founded because healthcare AI is moving faster than the systems designed to assess, fund, and adopt it. Promising technologies are reaching regulatory approval, but many still fail to scale because evidence requirements, reimbursement logic, procurement decisions, and clinical adoption pathways remain fragmented.

Through the VIS Platform, Valiant connects AI market intelligence with value assessment, evidence expectations, reimbursement pathways, and adoption signals - helping stakeholders move from fragmented information to better decisions. Valiant exists to close this gap.

“AI will only transform healthcare if its value is credible, comparable, and visible to those who decide whether it is adopted.”

Our Mission

Build shared European implementation infrastructure for healthcare AI, so promising technologies move from validation to adoption, funding and real-world impact.

Our Approach

Combine structured AI value assessment with real-world market intelligence - grounded in evidence, context, and system-level understanding.

Our Commitment

Responsible, transparent, and sustainable AI adoption: rigorous evidence, real-world signals over hype, and alignment with clinical and public trust.